NCT07303192

Brief Summary

This randomized clinical trial aims to evaluate whether injectable platelet-rich fibrin (i-PRF) and low-level laser therapy (LLLT) can reduce graft shrinkage after free gingival graft procedures. Free gingival grafts are commonly used to increase the width of keratinized tissue around teeth, but the graft often shrinks during healing. In this study, patients will receive standard free gingival graft surgery with or without additional i-PRF or laser therapy. The goal is to determine whether these treatments improve healing and help maintain the size of the graft.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
48

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jul 2024

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2024

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 30, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 30, 2025

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

December 11, 2025

Completed
13 days until next milestone

First Posted

Study publicly available on registry

December 24, 2025

Completed
Last Updated

December 24, 2025

Status Verified

December 1, 2025

Enrollment Period

1.2 years

First QC Date

December 11, 2025

Last Update Submit

December 11, 2025

Conditions

Keywords

free gingival graftshrinkagelow-level laser therapyinjectable platelet-rich fibrin

Outcome Measures

Primary Outcomes (4)

  • Graft Area Shrinkage (%)

    Change in graft surface area, expressed as percentage shrinkage from baseline. Standardized clinical photographs taken at baseline and at postoperative 1, 3, and 6 months were analyzed using calibrated digital image analysis software (ImageJ). The graft borders were traced, and surface area (mm²) was calculated. Each measurement was repeated three times, and the mean value was used. Shrinkage percentage was calculated using the formula: Shrinkage % = \[(baseline area - follow-up area) / baseline area\] × 100.

    Baseline, 1 month, 3 months, and 6 months postoperatively.

  • Root Coverage Percentage (%)

    Percentage of root coverage obtained at 6 months. Root coverage was calculated from changes in gingival recession depth (RD) using the formula: Root Coverage % = \[(baseline RD - RD at 6 months) / baseline RD\] × 100. RD was defined as the distance from the CEJ to the gingival margin and measured using a manual periodontal probe.

    Baseline and 6 months postoperatively.

  • Gingival Recession Depth (RD)

    Change in gingival recession depth measured in millimeters.

    Baseline, 1 month, 3 months, and 6 months postoperatively.

  • Keratinized Tissue Height (KTH)

    Change in keratinized tissue height measured in millimeters.

    Baseline, 1 month, 3 months, and 6 months postoperatively.

Secondary Outcomes (6)

  • Probing Depth (PD)

    Baseline, 1 month, 3 months, and 6 months postoperatively.

  • Clinical Attachment Level (CAL)

    Baseline, 1 month, 3 months, and 6 months postoperatively.

  • Oedema Score in the Recipient Site

    Postoperative days 3, 5, 7, 14, 21, and 28.

  • Erythema Score in the Recipient Site

    Postoperative days 3, 5, 7, 14, 21, and 28.

  • Pain Intensity (VAS Score)

    First postoperative week.

  • +1 more secondary outcomes

Study Arms (3)

Control Group

ACTIVE COMPARATOR

Patients receive free gingival graft only without additional treatment.

Procedure: Free Gingival Graft (FGG)

i-PRF group

EXPERIMENTAL

Patients receive free gingival graft with injectable platelet-rich fibrin applied to the graft surface.

Procedure: Free Gingival Graft (FGG)Device: Low-Level Laser Therapy (LLLT)

LLLT Group

EXPERIMENTAL

Patients receive free gingival graft with low-level laser therapy applied immediately after surgery and on postoperative days 3, 5, 7, and 14.

Procedure: Free Gingival Graft (FGG)Biological: Injectable Platelet-Rich Fibrin (i-PRF)

Interventions

Autologous platelet-rich fibrin gel is applied to the graft surface after free gingival graft surgery to potentially reduce graft shrinkage.

LLLT Group

Low-level laser therapy is applied to the graft site immediately after surgery and on postoperative days 3, 5, 7, and 14 to potentially improve healing and reduce graft shrinkage.

i-PRF group

Standard free gingival graft procedure performed without additional treatments.

Control GroupLLLT Groupi-PRF group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age \> 18 years.
  • Systemically healthy.
  • Cairo Class I gingival recession in vital mandibular anterior incisors.
  • No caries or restorations in the relevant teeth.
  • Keratinized gingiva height \< 2 mm in the included teeth.
  • Plaque Index (PI) \< 1.
  • Gingival Index (GI) \< 1.

You may not qualify if:

  • Active periodontal disease or probing depth \> 3 mm.
  • Use of medications that could prevent surgery or affect wound healing.
  • Pregnancy or breastfeeding.
  • History of periodontal surgery in the working area.
  • Active smokers.
  • Current orthodontic treatment.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Kahramanmaraş Sütçü İmam University

Kahramanmaraş, Turkey (Türkiye)

Location

Related Publications (1)

  • Shakiliyeva S, Sahin D, Gunpinar S, Gursel M. Comparison of conventional and modified sling suture techniques in free gingival graft operations-a randomized controlled clinical trial. BMC Oral Health. 2025 Feb 21;25(1):279. doi: 10.1186/s12903-025-05456-x.

    PMID: 39984903BACKGROUND

Related Links

MeSH Terms

Conditions

Gingival Recession

Interventions

proliferation regulatory factors, human urineLow-Level Light Therapy

Condition Hierarchy (Ancestors)

Gingival DiseasesPeriodontal DiseasesMouth DiseasesStomatognathic DiseasesPeriodontal Atrophy

Intervention Hierarchy (Ancestors)

Laser TherapyTherapeuticsPhototherapy

Study Officials

  • esra bozkurt

    Kahramanmaras Sutcu Imam University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

December 11, 2025

First Posted

December 24, 2025

Study Start

July 1, 2024

Primary Completion

August 30, 2025

Study Completion

August 30, 2025

Last Updated

December 24, 2025

Record last verified: 2025-12

Data Sharing

IPD Sharing
Will not share

Individual participant data will not be shared to ensure patient privacy and confidentiality.

Locations